Cartesian Therapeutics RNAC
NASDAQ RNAC
$7.18 -0.05 (-0.76%)
As of: Sep 30, 2026 · 10:01 AM EDT

Cartesian Therapeutics (RNAC) EV to CFO (2020 - 2021)

Updated

Cartesian Therapeutics' EV to CFO was 355.15 in Q2 2021, down 19.5% from the prior quarter.

Analysis

Cartesian Therapeutics (RNAC) EV to CFO (2020 - 2021) Analysis & Trends

On a trailing twelve-month basis, Cartesian Therapeutics' EV to CFO was 344.38 through Jun 30, 2021; for FY2020, it came in at 277.66.

  • Quarterly EV to CFO has moved between 267.72 (Q3 2020) and 440.95 (Q1 2021) over five years.
  • Per Business Quant data, RNAC's EV to CFO in the three quarters before Q2 2021 was 440.95 (Q1 2021), 277.66 (Q4 2020) and 267.72 (Q3 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Cartesian Therapeutics 216.57 Mn 216.57 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 355.15
Mar 31, 2021 440.95
Dec 31, 2020 277.66
Sep 30, 2020 267.72
API Access

Cartesian Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=RNAC&period=max&api_key=YOUR_API_KEY